Seagen Inc(NASDAQ:SGEN) 
Seagen Inc., a biotechnology company, develops and commercializes therapies for the treatment of cancer in the United States and internationally. The company markets ADCETRIS, an antibody-drug conjugate (ADC) for the treatment of patients with Hodgkin lymphoma or CD30-positive T-cell lymphomas; PADC...
Website: http://www.seattlegenetics.com
Founded: 1997
Full Time Employees: 1,605
Sector: Healthcare
Industry: Biotechnology
The information provided in this report is taken from www.sec.gov. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Day
Week
Month
Date 2023-06-26
P
O 198.00
H 198.40
L 196.43
C 196.54
V 1,147,610
10EMA 196.54
20EMA 196.54
60EMA 196.54
120EMA 196.54
250EMA 196.54